A PHASE 1/2 CLINICAL TRIAL FOR AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH LATE-ONSET OTC DEFICIENCY: INTERIM RESULTS FROM COHORT 1

被引:0
|
作者
Harding, Cary O. [1 ]
Geberhiwot, Tarekegn [2 ]
Aldamiz-Echevarria, Luis [3 ]
Luz Couce, Maria [4 ]
Khan, Anal [5 ]
Tan, Wen-Hann [6 ]
Crombez, Eric [7 ]
Diaz, George A. [8 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Univ Birmingham, Birmingham, W Midlands, England
[3] Hosp Univ Cruces, Baracaldo, Spain
[4] Univ Santiago de Compostela, Santiago De Compostela, Spain
[5] Univ Calgary, Calgary, AB, Canada
[6] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA
[7] Ultragenyx Gene Therapy, Cambridge, MA USA
[8] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:278 / 278
页数:1
相关论文
共 50 条
  • [1] A PHASE 1/2 CLINICAL TRIAL FOR AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH LATE-ONSET OTC DEFICIENCY: INTERIM RESULTS FROM COHORT 1
    Harding, Cary O.
    Geberhiwot, Tarekegn
    Aldamiz-Echevarria, Luis
    Luz Couce, Maria
    Khan, Aneal
    Tan, Wen-Hann
    Crombez, Eric
    Diaz, George A.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2019, 127 (03) : 240 - 240
  • [2] A phase 1/2 clinical trial for AAV8-mediated liver-directed gene therapy in adults with late-onset OTC deficiency
    Geberhiwot, T.
    Aldamiz-Echevarria, L.
    Couce, M. L.
    Harding, C. O.
    Khan, A.
    Tan, W. H.
    Lin, J.
    Crombez, E.
    Diaz, G. A.
    [J]. HUMAN GENE THERAPY, 2018, 29 (12) : A59 - A59
  • [3] Preliminary Results from Cohorts 1 and 2 of CAPtivate: A Phase 1/2 Clinical Trial of AAV8-Mediated Liver-Directed Gene Therapy in Adults with Late-Onset OTC Deficiency
    Diaz, George A.
    Harding, Cary O.
    Geberhiwot, Tarekegn
    Aldamiz-Echevarria, Luis
    Luz Couce, Maria
    Khan, Aneal
    Tan, Wen-Hann
    Crombez, Eric
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 2 - 3
  • [4] DESIGN OF AN OPEN LABEL PHASE 1/2 CLINICAL TRIAL FOR AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH LATE ONSET ORNITHINE TRANSCARBAMYLASE DEFICIENCY
    Harding, Cary O.
    Lin, Julie
    Crombez, Eric
    [J]. MOLECULAR GENETICS AND METABOLISM, 2018, 123 (03) : 198 - 198
  • [5] A phase 1/2 clinical trial of AAV8 gene therapy in adults with late-onset OTC deficiency: CAPtivate cohort 1+2 results
    Geberhiwot, T.
    Aldamiz-Echevarria, L.
    Couce, M. L.
    Diaz, G. A.
    Harding, C. O.
    Khan, A.
    Tan, W. H.
    Lee, C.
    Puga, A. C.
    Crombez, E.
    [J]. HUMAN GENE THERAPY, 2019, 30 (11) : A18 - A18
  • [6] AAV8 Gene Therapy as a Potential Treatment in Adults with Late-Onset OTC Deficiency: Results from a Phase 1/2 Clinical Trial
    Tan, Wen-Hann
    Geberhiwot, Tarekegn
    Couce, Maria Luz
    Aldamiz-Echevarria, Luis
    Diaz, George A.
    Harding, Cary O.
    Khan, Aneal
    Lee, Connie
    Puga, Ana Cristina
    Crombez, Eric
    [J]. MOLECULAR THERAPY, 2020, 28 (04) : 222 - 222
  • [7] Positive Cohort 1 Results from the Phase 1/2 Trial with AAV8-Mediated Liver-Directed Gene Therapy in Adults with Glycogen Storage Disease Type Ia
    Weinstein, David A.
    Ahmad, Ayesha
    Lee, Connie
    Poma, Allen
    Crombez, Eric
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 12 - 12
  • [8] COHORT 1-4 RESULTS FROM A PHASE 1/2 CLINICAL TRIAL OF AN AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA (GSDIA)
    Rodriguez-Buritica, David F.
    Ahmad, Ayesha
    Pico, Maria-Luz Couce
    Derks, Terry G.
    Mitchell, John
    Riba-Wolman, Rebecca
    Weinstein, David A.
    Lee, Connie
    Valayannopoulos, Vassili
    Crombez, Eric
    [J]. MOLECULAR GENETICS AND METABOLISM, 2022, 135 (04) : 296 - 296
  • [9] Positive cohort 1 results from the phase 1/2, AAV8-mediated liver-directed gene therapy trial in glycogen storage disease type Ia (GSDIa)
    Derks, T. G.
    Martin-Hernandez, E.
    Ahmad, A.
    Rodriguez-Buritica, D.
    Mitchell, J.
    Lee, C.
    Poma, A.
    Crombez, E.
    Weinstein, D. A.
    [J]. HUMAN GENE THERAPY, 2019, 30 (11) : A14 - A14
  • [10] AAV8 Gene Therapy as a Potential Treatment in Adults with Late-Onset Ornithine Transcarbamylase (OTC) Deficiency: Updated Results from a Phase 1/2 Clinical Trial
    Harding, Cary O.
    Luz Couce, Maria
    Geberhiwot, Tarekegn
    Tan, Wen-Hann
    Khan, Aneal
    Aldamiz-Echevarria, Luis
    Diaz, George A.
    Lee, Connie
    Puga, Ana Cristina
    Crombez, Eric
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 17 - 17